David L. Brinkley, Senior VP Commercial Development at THERAVANCE INC (THRX), sold 2,986 shares at $33.50 ($100K) on 2007-06-15, disclosed to the SEC on 2007-06-19.
Scheduled sale ($100k) by Senior VP Commercial Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.49 | 83 | $3K | 2.8% |
| 2 | $33.50 | 922 | $31K | 30.8% |
| 3 | $33.54 | 100 | $3K | 3.3% |
| 4 | $33.55 | 1,000 | $34K | 33.5% |
| 5 | $33.56 | 200 | $7K | 6.7% |
| 6 | $33.60 | 100 |
| $3K |
| 3.4% |
| 7 | $33.65 | 241 | $8K | 8.1% |
| 8 | $33.69 | 300 | $10K | 10.1% |
| 9 | $33.70 | 40 | $1K | 1.3% |
| Total | $33.56 avg | 2,986 | $100K | 100% |
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |